China BlueChemical Ltd.
China BlueChemical Ltd. Fundamental Analysis
China BlueChemical Ltd. (CBLUY) shows weak financial fundamentals with a PE ratio of 17.07, profit margin of 6.05%, and ROE of 2.23%. The company generates $6.9B in annual revenue with weak year-over-year growth of -1.87%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 38.7/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze CBLUY's fundamental strength across five key dimensions:
Efficiency Score
WeakCBLUY struggles to generate sufficient returns from assets.
Valuation Score
ExcellentCBLUY trades at attractive valuation levels.
Growth Score
WeakCBLUY faces weak or negative growth trends.
Financial Health Score
ExcellentCBLUY maintains a strong and stable balance sheet.
Profitability Score
ModerateCBLUY maintains healthy but balanced margins.
Key Financial Metrics
Is CBLUY Expensive or Cheap?
P/E Ratio
CBLUY trades at 17.07 times earnings. This indicates a fair valuation.
PEG Ratio
When adjusting for growth, CBLUY's PEG of -0.28 indicates potential undervaluation.
Price to Book
The market values China BlueChemical Ltd. at 0.38 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 8.64 times EBITDA. This is generally considered low.
How Well Does CBLUY Make Money?
Net Profit Margin
For every $100 in sales, China BlueChemical Ltd. keeps $6.05 as profit after all expenses.
Operating Margin
Core operations generate 4.15 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $2.23 in profit for every $100 of shareholder equity.
ROA
China BlueChemical Ltd. generates $1.67 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
China BlueChemical Ltd. produces operating cash flow of $717.42M, showing steady but balanced cash generation.
Free Cash Flow
China BlueChemical Ltd. produces free cash flow of $303.88M, offering steady but limited capital for shareholder returns and expansion.
FCF Per Share
Each share generates $3.30 in free cash annually.
FCF Yield
CBLUY converts 4.28% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
17.07
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
-0.28
vs 25 benchmark
P/B Ratio
Price to book value ratio
0.38
vs 25 benchmark
P/S Ratio
Price to sales ratio
1.03
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.11
vs 25 benchmark
Current Ratio
Current assets to current liabilities
4.62
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.02
vs 25 benchmark
ROA
Return on assets percentage
0.02
vs 25 benchmark
ROCE
Return on capital employed
0.01
vs 25 benchmark
How CBLUY Stacks Against Its Sector Peers
| Metric | CBLUY Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 17.07 | 24.08 | Better (Cheaper) |
| ROE | 2.23% | 921.00% | Weak |
| Net Margin | 6.05% | -113338.00% (disorted) | Weak |
| Debt/Equity | 0.11 | 0.53 | Strong (Low Leverage) |
| Current Ratio | 4.62 | 5.09 | Strong Liquidity |
| ROA | 1.67% | -9816.00% (disorted) | Weak |
CBLUY outperforms its industry in 3 out of 6 key metrics, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews China BlueChemical Ltd.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
12.53%
Industry Style: Cyclical, Commodity, Value
High GrowthEPS CAGR
27.33%
Industry Style: Cyclical, Commodity, Value
High GrowthFCF CAGR
-100.00%
Industry Style: Cyclical, Commodity, Value
Declining